First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Journal article
Cicconi P. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70, 2073 - 2081
Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
Journal article
McNaughton AL. et al, (2019), Scientific Reports, 9
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Journal article
Green CA. et al, (2019), The Journal of infection, 78, 382 - 392
Single-cell transcriptome analysis of CD8 + T-cell memory inflation.
Journal article
Highton AJ. et al, (2019), Wellcome open research, 4
Humoral and cellular immunity to RSV in infants, children and adults
Journal article
Green CA. et al, (2018), Vaccine, 36, 6183 - 6190
Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order
Journal article
Lee LN. et al, (2017), PLOS Pathogens, 13, e1006782 - e1006782
MAIT cells are activated during human viral infections
Journal article
van Wilgenburg B. et al, (2016), Nature Communications, 7
Adenoviral Vector Vaccination Induces a Conserved Program of CD8+ T Cell Memory Differentiation in Mouse and Man
Journal article
Bolinger B. et al, (2015), Cell Reports, 13, 1578 - 1588
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
Journal article
Green CA. et al, (2015), BMJ Open, 5, e008748 - e008748
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
Journal article
Green CA. et al, (2015), Science Translational Medicine, 7, 300ra126 - 300ra126
CD 161 ++ CD 8 + T cells, including the MAIT cell subset, are specifically activated by IL ‐12+ IL ‐18 in a TCR ‐independent manner
Journal article
Ussher JE. et al, (2014), European Journal of Immunology, 44, 195 - 203
Accelerated In Vivo Proliferation of Memory Phenotype CD4+ T-cells in Human HIV-1 Infection Irrespective of Viral Chemokine Co-receptor Tropism
Journal article
Zhang Y. et al, (2013), PLoS Pathogens, 9, e1003310 - e1003310
A New Model for CD8+T Cell Memory Inflation Based upon a Recombinant Adenoviral Vector
Journal article
Bolinger B. et al, (2013), The Journal of Immunology, 190, 4162 - 4174
Simultaneous Immunization against Tuberculosis
Journal article
Tchilian EZ. et al, (2011), PLoS ONE, 6, e27477 - e27477
CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis
Journal article
Lee LN. et al, (2011), Infection and Immunity, 79, 3328 - 3337
Human cytomegalovirus-specific CD8+ T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects
Journal article
Wallace DL. et al, (2011), Immunology, 132, 27 - 38
Accelerated CD4(+) T cell turnover in HIV infection preferentially drives proliferation of CCR5(+) cells regardless of HIV viral co-receptor tropism
Conference paper
Zhang Y. et al, (2010), IMMUNOLOGY, 131, 126 - 127
Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose
Journal article
Macallan DC. et al, (2009), Nature Protocols, 4, 1313 - 1327
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection
Journal article
Zhang Y. et al, (2007), Immunology, 121, 258 - 265
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection
Journal article
Asquith B. et al, (2007), Proceedings of the National Academy of Sciences, 104, 8035 - 8040